Impact BioMedical Inc. (IBO)
Market Open
26 Oct, 07:20 PM
AMEX AMEX Primary $
3. 20
-0.4
-11.1111%
$
30.76M Market Cap
- P/E Ratio
- Div Yield
93 Volume
- Eps
$ 3.6
Previous Close Investors:
Want to track IBO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Impact BioMedical Inc. (IBO) Statistics
Valuation metrics
Market Cap 30.76M
Enterprise value 30.75M
Trailing P/E (ttm) -2.92
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) 878.78
Price/Book (mrq) 2.86
Enterprise Value/Revenue 878.49
Enterprise Value/EBITDA -76.68
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 20.32K
Average volume (90 days) 14.32K
Price summary
52-Week low 2.43
52-Week high 10.51
Beta -
50-Day moving average 5.18
200-Day moving average 5.31
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 5 Jun 2020
Ex-Dividend Date 14 May 2020
Last split factor 1:12
Last split Date 23 Sep 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 22.54%
Operating margin -145.63%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.14%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.09
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 0.16%
Book value per share (mrq) 1.64
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
